Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

Showing session: reset

ALL MODES LEAD TO PrEP

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 9 of 9
CABOTEGRAVIR PHARMACOLOGY IN THE BACKGROUND OF DELAYED INJECTIONS IN HPTN 084   (ABSTRACT 159)
Mark A. Marzinke
The Johns Hopkins University School of Medicine, Baltimore, MD, United States
from CROI 2023 on February 21, 2023 10:00 AM-12:00 PM
THE LEVI SYNDROME: CHARACTERISTICS OF EARLY HIV INFECTION WITH CABOTEGRAVIR FOR PrEP   (ABSTRACT 160)
Susan H. Eshleman
The Johns Hopkins University School of Medicine, Baltimore, MD, United States
from CROI 2023 on February 21, 2023 10:00 AM-12:00 PM
CABOTEGRAVIR FOR HIV PrEP IN US BLACK MEN AND TRANSGENDER WOMEN WHO HAVE SEX WITH MEN   (ABSTRACT 161)
Hyman Scott
San Francisco Department of Public Health, San Francisco, CA, United States
from CROI 2023 on February 21, 2023 10:00 AM-12:00 PM
CAB LA FOR HIV PREVENTION IN AFRICAN CISGENDER FEMALE ADOLESCENTS (HPTN 084-01)   (ABSTRACT 162)
Sybil Hosek
Stroger Hospital of Cook County, Chicago, IL, United States
from CROI 2023 on February 21, 2023 10:00 AM-12:00 PM
QUESTIONS AND ANSWERS (Part 1)
Jean-Michel Molina
University of Paris Cité, Paris, France
Valdilea Veloso
Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil
from CROI 2023 on February 21, 2023 10:00 AM-12:00 PM
8+ YEARS POOLED ANALYSIS: ADHERENCE AND HIV INCIDENCE IN 6000 WOMEN ON F/TDF FOR PrEP   (ABSTRACT 163)
Jeanne Marrazzo
University of Alabama at Birmingham, Birmingham, AL, United States
from CROI 2023 on February 21, 2023 10:00 AM-12:00 PM
SAFETY AND PK/PD OF A TENOFOVIR ALAFENAMIDE/ELVITEGRAVIR INSERT ADMINISTERED RECTALLY   (ABSTRACT 164)
Sharon A. Riddler
University of Pittsburgh, Pittsburgh, PA, United States
from CROI 2023 on February 21, 2023 10:00 AM-12:00 PM
ULTRA LONG-ACTING REFILLABLE ISLATRAVIR IMPLANT FULLY PROTECTS NHP AGAINST SHIV   (ABSTRACT 165)
Alessandro Grattoni
Houston Methodist Research Institute, Houston, TX, United States
from CROI 2023 on February 21, 2023 10:00 AM-12:00 PM
QUESTIONS AND ANSWERS (Part 2)
Jean-Michel Molina
University of Paris Cité, Paris, France
Valdilea Veloso
Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil
from CROI 2023 on February 21, 2023 10:00 AM-12:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 9 of 9